| Geraldine McDowell |
Geraldine McDowell is currently the Senior Technical Director & Vice President at Laboratory Corp. of America Holdings. Previously, she worked as a Member at the American College of Medical Genetics & Genomics from 2000 to 2003 and as a Member at the College of American Pathologists. She holds a doctorate degree from the University of Maryland School of Medicine. |
| Marcia T. Eisenberg |
Dr. Marcia T. Eisenberg is an Independent Director at Singular Genomics Systems, Inc., an Independent Director at 908 Devices, Inc., a Chief Scientific Officer-Enterprise at Laboratory Corp. of America Holdings and a Member of Federal Bureau of Investigation. She is on the Board of Directors at Singular Genomics Systems, Inc., 908 Devices, Inc. and OmniSeq, Inc. She received her undergraduate degree from State University of New York at Albany, a graduate degree from State University of New York at Albany and a doctorate degree from the University of Kentucky. |
| Brian J. Caveney |
Brian J. Caveney is currently the Director at Carolina Advanced Health and the Chief Medical & Scientific Officer, Executive VP at Laboratory Corp. of America Holdings. Previously, he held positions as the Director at Urgent Cares of America Holdings LLC, Chief Medical Officer at Blue Cross & Blue Shield of North Carolina, Assistant Professor at Duke University Medical Center, President at American College of Occupational & Environmental Medicine, and Chief Clinical Officer at NobleHealth, Inc. Dr. Caveney obtained a doctorate degree from West Virginia University in 2002, a graduate degree from The University of North Carolina at Charlotte in 2004, and a graduate degree from West Virginia University School of Medicine. |
| Mark S. Schroeder |
Mark S. Schroeder is currently the COO, Executive VP & President-Diagnostics at Laboratory Corp. of America Holdings since 2023. He is also an Advisor at Flare Capital Management Co. LLC. Previously, he worked as the VP-Sales, Operations & Business Development at CJ Logistics, Inc. from 1994 to 2007. Mr. Schroeder completed his undergraduate degree at Clarkson University in 1988. |
| Amy B. Summy |
Amy B. Summy is the founder of No More Kids With Cancer. She is currently the Chief Marketing Officer & Executive Vice President at Laboratory Corp. of America Holdings and a Member-Visitors Board at The Children's Hospital of Philadelphia. Previously, she was the Chief Marketing Officer & Managing Director at SapientNitro USA, Inc. and Publicis Sapient China Co., Ltd. She also served as the Chief Marketing Officer & Senior Vice President at TE Connectivity Ltd. and was a Partner at Ernst & Young LLP. Ms. Summy received her undergraduate degree from Kent State University (Ohio) and another undergraduate degree from The Leonard N Stern School of Business. |
| Glenn Andrew Eisenberg |
Glenn Andrew Eisenberg is currently the Director at Labcorp Drug Development, Inc., Sciformix Corp., Theorem Research Associates, Inc., The Aultman Health Foundation, Chiltern International Ltd., MAPI, Inc., Labcorp Early Development Laboratories Ltd., Correlagen Diagnostics, Inc., The Aultman Hospital, Labcorp International Group Ltd., Fortrea Development Ltd., Fortrea Clinical Research Unit Ltd., Fortrea UK Holdings Ltd., Labcorp Early Development Services GmbH, Ockham Europe Ltd., Clearstone Holdings (International) Ltd., Labcorp International Holdings Ltd., LabCorp UK Holdings Ltd., LabCorp Neon Ltd., and Solventum Corp. He is also the Co-Managing Director at Labcorp Early Development Services GmbH. Mr. Eisenberg previously worked as the Chief Financial Officer & Executive Vice President at Laboratory Corp. of America Holdings, Vice President at DIANON Systems, Inc., Chief Financial Officer at Sequenom, Inc., and Executive Vice President at Protedyne Corp. He was also the Vice President at LipoScience, Inc. In his former roles, Mr. Eisenberg served as the Independent Director at US Ecology Holdings, Inc., Family Dollar Stores LLC, Alpha Natural Resources, Inc., and Perspecta, Inc. He was the Lead Independent Director at Old ANR LLC and served as a Director at the Federation of Jewish Community Services of Montreal. He also held the position of Independent Director at US Ecology, Inc. and served as the Chief Financial Officer & Executive Vice President at SPX Corp. He was the Executive Vice President-Finance & Administration at The Timken Co. and President & Chief Operating Officer at United Dominion Industries Ltd. He was also the President at Citizens & Southern Corp. (Georgia) and Timken U.S. Holdings LLC. Mr. Eisenberg obtained an MBA from Georgia State University in 1988 and completed his undergraduate studies at Tulane University (Louisiana) in 1982. |
| Peter J. Wilkinson |
Peter J. Wilkinson is currently the Chief Accounting Officer & Senior Vice President at Laboratory Corp. of America Holdings. He is also a Trustee at Leeds Grand Theatre & Opera House Ltd. Previously, he served as the Chief Financial & Accounting Officer at Pharmaceutical Product Development LLC from 2003 to 2012. He was also the Corporate Controller at Catalyst Health Solutions, Inc. and a Senior Manager at Deloitte & Touche LLP. In 2016 and 2017, he held the position of Chief Accounting Officer & Senior Vice President at INC Research Holdings, Inc. From 2017 to 2018, he was the Executive Vice President & CFO-Clinical Division at Syneos Health, Inc. Mr. Wilkinson completed his undergraduate degree at Liberty University. |
| Sandra Danett van der Vaart |
Sandra Danett van der Vaart is currently the Chief Executive Officer & Secretary at Monogram Biosciences, Inc. and Theorem Research Associates, Inc. She is also the Director at Labcorp UK Ltd., Chiltern International Ltd., Labcorp Research Ltd., Labcorp Early Development Laboratories Ltd., Fortrea Development Ltd., Fortrea Clinical Research Unit Ltd., Covance CRS Analytics Ltd., Labcorp International Holdings Ltd., LabCorp UK Holdings Ltd., LabCorp Neon Ltd., and Covance Consulting Ltd. Additionally, she holds the position of Secretary, Chief Legal Officer & Executive VP at Laboratory Corp. of America Holdings. Previously, she served as the President & Secretary at DIANON Systems, Inc., Sequenom, Inc., Protedyne Corp., and LipoScience, Inc. She was also a Member of the Association of Corporate Counsel. In her former roles, she was the Chairman-Health Law Section Council at The North Carolina Bar Association, Director-Managed Care Department at North Carolina Medical Society, and Member-Health Care Practice Group at Smith, Helms, Mulliss & Moore. She also served as the President of the North Carolina Society of Health Care Attorneys. Ms. van der Vaart holds a graduate degree from the University of Virginia and an undergraduate degree from The University of North Carolina at Charlotte. |
| Anita Z. Graham |
Anita Z. Graham is currently the Chief Human Resources Officer & Executive VP at Laboratory Corp. of America Holdings. Previously, she held positions as Vice President-Human Resources at Cytyc Corp., Chief Administrative Officer at Shire Plc from 2004 to 2008, Chief Human Resources Officer & Vice President at VF Corp. from 2014 to 2023, Chief Administrative Officer at Shire Acquisition, Inc. from 2004 to 2008, Chief Administrative Officer & Executive VP at Shire Plc, Chief Human Resources & Administrative Officer at The ADT Security Corp. from 2012 to 2013, Principal-Human Resources at Zurich Scudder Investments, Inc., and Head-Human Resources at EMD Serono, Inc. Ms. Graham completed her undergraduate degree at Cornell University and holds an MBA from The Leonard N Stern School of Business. |
| Lance V. Berberian |
Lance V. Berberian is currently the Chief Information & Technology Officer & EVP at Laboratory Corp. of America Holdings since 2020. He is also a Trustee at Elon University. Previously, he served as the Chief Information Officer at IDEXX Laboratories, Inc. from 2007 to 2014. Prior to that, he held the position of Chief Information Officer at Interim HealthCare, Inc. in 2000. From 2000 to 2007, he was the President & Chief Information Officer at Kellstrom Commercial Aerospace, Inc. Mr. Berberian completed his undergraduate degree at Thomas Edison State College. |
| Adam H. Schechter |
Adam H. Schechter is currently the Chairman, President & Chief Executive Officer at Laboratory Corp. of America Holdings. He is also the Vice Chairman at American Clinical Laboratory Association, an Independent Director at DaVita, Inc., a Director at the European Federation of Pharmaceutical Industries & Assns, and a Director at Water.org, Inc. Additionally, he serves as the President at Laboratory Corporation of America, Inc. Previously, Mr. Schechter held the position of Executive Director at The National Alliance For Hispanic Health. He worked at Merck & Co., Inc. from 1988 to 2018, where he served as Executive VP & President-Global Human Health. He also worked at Merck Sharp & Dohme Corp. from 2002 to 2009, holding the position of President-Global Human Health & Executive VP. Mr. Schechter completed his undergraduate degree at LaSalle University. |
| Jonathan DiVincenzo |
Mr. Jonathan DiVincenzo is a President-Central Laboratories & International at Laboratory Corp. of America Holdings. He is on the Board of Directors at Analytical Life Science & Diagnostics Association. Mr. DiVincenzo was previously employed as a President, Chief Executive Officer & Director by Enzymatics, Inc. (Massachusetts), a President-Bioscience Division by EMD Millipore Corp., a Member-Innovation by CEB, Inc., and a President-Environmental Health & Senior VP by Revvity, Inc. He received his undergraduate degree from Northeastern University. |
| Robert Sanders Williams |
Robert Sanders Williams is currently an Independent Director at Amgen, Inc., Laboratory Corp. of America Holdings, Exploratorium, Gladstone Foundation (CA), Tenaya Therapeutics, Inc., and a Professor at Duke University. He is also the Vice President-Research & Innovation at The University of California, San Francisco and a Member of the National Academy of Medicine (United States), Association of American Physicians, and American Society for Clinical Investigation. Previously, he served as the President of The J. David Gladstone Institutes from 2009 to 2017 and held positions as an Independent Director at Bristol Myers Squibb Co. from 2006 to 2013, Chief-Cardiology & Director-Ryburn Center at The University of Texas Southwestern Medical Center from 1990 to 2001, and Senior Vice Chancellor at Duke University Medical Center from 2001 to 2010. He also served as the Dean & Senior Vice Chancellor at Duke University School of Medicine from 2001 to 2010. Dr. Williams holds a doctorate degree from Duke University and an undergraduate degree from Princeton University. |
| Kirsten M. Kliphouse |
Kirsten M. Kliphouse is the founder of Scaling Ventures. She currently holds multiple positions including Chairman at Aspiring Leadership Academy, Independent Director at Laboratory Corp. of America Holdings, Independent Director at Global Payments, Inc., and Director at Dun & Bradstreet Holdings, Inc. Her former positions include Chief Executive Officer at Yardarm Technologies, Inc., Vice President & Partner at Microsoft Corp., Senior Vice President at Red Hat, Inc., and President-American Region at Google Cloud. She received her undergraduate degree from Muhlenberg College. |
| Paul B. Rothman |
Paul B. Rothman is an Independent Director at Laboratory Corp. of America Holdings and Merck & Co., Inc. He is also a Director at Merck Sharp & Dohme Corp., King Faisal Specialist Hospital & Research Centre, MSD Pharma (Singapore) Pte Ltd., and Center for Medical Interoperability. He is a Member of the American Academy of Arts & Sciences, American Association for the Advancement of Science, National Academy of Medicine (United States), Association of American Physicians, and American Society for Clinical Investigation. He is an Ex-Officio Trustee at The Johns Hopkins Hospital, Inc. and a Trustee at Johns Hopkins Community Physicians, Inc. His former positions include Chief Executive Officer at Johns Hopkins Medicine, Inc., Dean at the University of Iowa Carver College of Medicine, and Director at Cancer Genetics, Inc. He holds an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Yale University. |
| Garheng Kong |
Garheng Kong founded Healthquest Capital Management Co LLC in 2012, where he is working as Managing Partner from 2012. Dr. Kong also currently works at Ajax Health LLC, as Chairman of the Board from 2019, Laboratory Corp. of America Holdings, as Independent Director from 2013, Magnolia Medical Technologies, Inc., as Director, and various other companies. Dr. Kong also formerly worked at Serenex, Inc., as Chairman of the Board from 2002 to 2008, Viamet Pharmaceuticals, Inc., as Chairman of the Board from 2005 to 2010, Histogenics Corp., as Chairman from 2012 to 2019, and various other companies. Dr. Kong received his graduate degree, Masters Business Admin degree, and doctorate degree from Duke University and undergraduate degree from Stanford University. |
| Richelle P. Parham |
Richelle P. Parham currently works at Best Buy Co., Inc., as Independent Director from 2018, Laboratory Corp. of America Holdings, as Independent Director from 2016, Ranir LLC, as Director from 2017, e.l.f. Cosmetics, Inc., as Director from 2018, Universal Music Group, Inc., as President-Global E-Commerce & Business Development from 2021, and Drexel University, as Trustee from 2014. Ms. Parham also formerly worked at Scripps Networks Interactive, Inc., as Independent Director from 2012 to 2018, e.l.f. Beauty, Inc., as Independent Director from 2018 to 2022, WestRiver Management LLC, as Managing Director & Partner from 2019 to 2021, TOCA Football, Inc., as Director, Shyn, Inc., as Director, eBay, Inc., as Chief Marketing Officer & Vice President from 2010 to 2015, Digitas, Inc., as Vice President & General Manager from 1994 to 2007, Camden Partners Holdings LLC, as General Partner from 2016 to 2019, Visa, Inc., as Head-Global Marketing Innovation in 2010, and Rapp Collins Worldwide, Inc., as Senior Vice President-Strategy & Enablement from 2007 to 2008. Ms. Parham received her undergraduate degree from Drexel University. |
| Kerrii B. Anderson |
Kerrii B. Anderson is currently the Chairman-Trustees Board at Elon University since 2016. She is also an Independent Director at Laboratory Corp. of America Holdings since 2006, The Sherwin-Williams Co. since 2019, Worthington Enterprises, Inc. since 2010, Abercrombie & Fitch Co. since 2018, and a Director at OhioHealth Corp. In her former positions, Ms. Anderson served as the President, Chief Executive Officer & Director at Wendy's International LLC from 2006 to 2008. She was the Non-Executive Chairman at Chiquita Brands International, Inc. from 2012 to 2015. Additionally, she was a Director at Lancaster Colony Corp. in 2005, an Independent Director at P.F. Chang's China Bistro, Inc. from 2011 to 2012, and the Chief Financial Officer & Senior Vice President at M from 1987 to 2000. She also served as a Trustee at The Columbus Foundation, Inc.
Ms. Anderson completed her undergraduate degree at Elon University and holds an MBA from The Fuqua School of Business. |
| D. Gary Gilliland |
D. Gary Gilliland is currently an Independent Director at Laboratory Corp. of America Holdings and Nuvalent, Inc. He is also a Member of the American Academy of Arts & Sciences, the National Academy of Medicine (United States), the Association of American Physicians, and the American Society of Clinical Investigation. Previously, he served as the President & Director of the Fred Hutchinson Cancer Research Center from 2015 to 2020. He was also the Director-Leukemia Program at Dana-Farber from 2002 to 2009 and the Director-Cancer Stem Cell Program at the Harvard Stem Cell Institute in 2009. Additionally, he held positions as a Senior Vice President at Merck & Co., Inc. from 2009 to 2013 and as a Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2009 to 2013. He was a Senior Vice President at The University of Pennsylvania Health System and a Senior Vice President at the Trustees of the University of Pennsylvania from 2013 to 2015. He was a Vice Dean & Professor at the Perelman School of Medicine from 2013 to 2020. Gilliland's education includes a doctorate from the University of California, Los Angeles, an undergraduate degree from the University of California, Davis, and another doctorate from the University of California, San Francisco. |
| Kathryn E. Wengel |
Kathryn E. Wengel is currently serving as the Vice Chairman at the National Association of Manufacturers and as the Chairman-Management Board at GS1 AISBL. She is also an Independent Director at Laboratory Corp. of America Holdings and a Member at Associazione Nazionale Produttori Illuminazione. In addition, Ms. Wengel has a background in undergraduate studies from Princeton University. |
| Peter M. Neupert |
Mr. Peter M. Neupert is an Independent Director at Fortrea Holdings, Inc., a Lead Independent Director and Board Member at Adaptive Biotechnologies Corp. and an Independent Director at Laboratory Corp. of America Holdings. He is on the Board of Directors at Fortrea Holdings, Inc., Navigating Cancer, Inc., Adaptive Biotechnologies Corp., Clinithink Ltd., Laboratory Corp. of America Holdings, Kernel Labs Holding LLC, America Holdings, A California LP, Cranium, Inc., GlobalScholar Corp. and Vitalchat Inc. Mr. Neupert was previously employed as a Board Member by Truveta, Inc., a Board Member by higi SH LLC, a Board Member by Freedom Innovations LLC, an Operating Partner by Health Evolution Management Co. LLC, a Trustee by Fred Hutchinson Cancer Research Center, a Member by Institute of Medicine, a Board Member by aQuantive, Inc., a Chairman of BoD by drugstore.com, Inc., and a Vice President-Health Solutions Group by Microsoft Corp. He also served on the board at Quality Systems, Inc., aQuantive, Inc. and Foundation for the National Institutes of Health, Inc. He received his undergraduate degree from The Colorado College and an MBA from Tuck School of Business at Dartmouth. |
| Jean-Luc Bélingard |
Jean-Luc Bélingard is currently a Member-CEO Roundtable at Bill & Melinda Gates Foundation Trust. He is also an Independent Director at Laboratory Corp. of America Holdings, a Director at Transgene SA, a Non-Independent Director at bioMérieux SA, an Independent Non-Executive Director at Lupin Ltd., a Director at Lupin Pharmaceuticals, Inc., a Director at bioMERIEUX Benelux SANV, a Director at Laboratoire Pierre Fabre Oncologie, a Director at Laboratory Corporation of America, Inc., a Director at Stallergenes Greer, Inc., a Director at Lupin Atlantis Holdings SA, a Director at Lupin, Inc., an Operating Advisor at Clayton Dubilier & Rice LLC, and a Vice President at Institut Mérieux SA. Previously, Mr. Bélingard served as the Chairman & Chief Executive Officer of Ipsen SA from 2002 to 2010. He was also the Chief Executive Officer of Ipsen Pharma SA from 2001 to 2010. Additionally, he held the position of Chief Executive Officer & Director at Biomerieux Pierre Fabre SA from 1999 to 2001 and Chief Executive Officer of Roche Diagnostics France SASU from 1990 to 1999. He served as the Chairman of Fédération Françaises des Industries de Santé from 2016 to 2019. Mr. Bélingard's education includes an MBA from Cornell University in 1974 and an undergraduate degree from École des Hautes Études Commerciales de Paris in 1971. |
| Jeffrey Allan Davis |
Jeffrey Allan Davis is currently an Independent Director at Laboratory Corp. of America Holdings, a Director at The First Tee of Northwest Arkansas, a Chief Financial Officer at Dollar Tree, Inc., and a Member of the National Association of Black Accountants, Inc. In the past, he served as a Non-Executive Director at Massmart Holdings Ltd., a Director at Washington Regional Medical Center and Financial Executives International, a Chief Financial Officer & Executive Vice President at Old COPPER Co., Inc., Walmart, Inc., Darden Restaurants, Inc., and Qurate Retail, Inc., and a Principal at The Hillman Co. He was also a Trustee at National Urban League, Inc. and Collegiate School. Mr. Davis received his undergraduate degree from The Pennsylvania State University and his MBA from Joseph M. Katz Graduate School of Business. |
